Darunavir (TMC114): a new HIV-1 protease inhibitor

By Molina Jean-Michel   Hill Andrew  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1951-1964

Informa Healthcare

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics and Safety of Bevirimat, a Novel Inhibitor of HIV Maturation, in Healthy Volunteers

By Martin David E.  

Clinical Pharmacokinetics, Vol. 46, Iss. 7, 2007-01 ,pp. : 589-598

Adis International

Access to resources Recommend Favorite

Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers

By Dumont G.   Wezenberg E.   Valkenberg M.   Jong C.   Buitelaar J.   Gerven J.   Verkes R.  

Psychopharmacology, Vol. 197, Iss. 3, 2008-04 ,pp. : 465-474

Springer Publishing Company

Access to resources Recommend Favorite

Effect of reboxetine on the pharmacokinetics of lorazepam in healthy volunteers

By Jannuzzo M.G.   Dostert P.   Strolin Benedetti M.   Bosc M.   Renoux A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 300-301

Elsevier

Access to resources Recommend Favorite

Probenecid Affects the Pharmacokinetics of Ofloxacin in Healthy Volunteers

By Nataraj B.  

Clinical Drug Investigation, Vol. 16, Iss. 3, 1998-09 ,pp. : 259-262

Adis International

Access to resources Recommend Favorite